Vaccine development against Neisseria meningitidis
Meningococcal disease is communicable by close contact or droplet aerosols. Striking features are high case fatality rates and peak incidences of invasive disease in infants, toddlers and adolescents. Vaccine development is hampered by bacterial immune evasion strategies including molecular mimicry....
Main Authors: | Vogel, Ulrich, Claus, Heike |
---|---|
Format: | Online |
Language: | English |
Published: |
Blackwell Publishing Ltd
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815792/ |
Similar Items
-
The Development of an Experimental Multiple Serogroups Vaccine for Neisseria meningitidis
by: Pinto, Valerian B., et al.
Published: (2013) -
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
by: Masignani, Vega, et al.
Published: (2003) -
Virulence Evolution of the Human Pathogen Neisseria meningitidis by Recombination in the Core and Accessory Genome
by: Joseph, Biju, et al.
Published: (2011) -
Description and Nomenclature of Neisseria meningitidis Capsule Locus
by: Harrison, Odile B., et al.
Published: (2013) -
Rifampin-resistant Neisseria meningitidis
by: Taha, Muhamed-Kheir, et al.
Published: (2006)